Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Observational study on factors affecting chronic heart failure prognosis

Official title: Cohort Study of Chronic Heart Failure

Run by Jiangsu Taizhou People's Hospital · NCT05960890 · Data updated 2026-11-12

This study looks at how different factors, like genetics and lifestyle, affect the health and future of people with chronic heart failure to help improve their care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorJiangsu Taizhou People's Hospital
Academic / other
Locations1 site (Taizhou, Jiangsu)
StatusRecruiting
StartedJune 8, 2023
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedMay 20, 2026
Trial IDNCT05960890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with specific types of cardiomyopathy and heart failure symptoms.

Probably not a fit

Patients with severe renal insufficiency, life expectancy less than 3 months, or cardiac insufficiency from correctable causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify the factors influencing the prognosis of chronic heart failure in patients. It will collect various omics data, including phenotype, environmental exposure, intestinal microbiome, genome, metabolome, and noninvasive biomarkers, to understand their impact on clinical outcomes. The study focuses on patients with specific types of cardiomyopathy and heart failure symptoms. By analyzing this data, researchers hope to gain insights into improving patient management and outcomes.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of chronic heart failure, ultimately improving patient outcomes.

How similar studies have gone: Other studies have explored similar factors in heart failure, but this specific approach to integrating multiple omics data is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years;
2. Fulfill at least one of the following criteria:①History of chronic heart failure;②New-onset heart failure with LVEF \<50%;③New-onset heart failure with LVEF≧50%,E/e'≧15 and BNP\>400 pg/mL/NT-proBNP(\<50 years, \>450 pg/mL; 50\~75 years, \>900 pg/mL; \>75 years, \>1800 pg/mL)
3. Etiology: dilated cardiomyopathy, hypertensive heart disease, ischaemic cardiomyopathy, Non-severe valvular heart disease;
4. Primary post-discharge therapy: oral medication;
5. Sign the informed consent form.

Exclusion Criteria:

1. Patients with renal failure (Ccr\<30ml/min) or patients on dialysis therapy;
2. Various correctable secondary causes of cardiac insufficiency including hyperthyroid heart disease, anaemic heart disease, uncorrected congenital heart disease; severe valvular heart disease (including severe stenosis or closure of organic aortic and mitral valves);
3. Patients with indications for pacemaker implantation but have not received a pacemaker implant;
4. Patients with chronic obstructive pulmonary disease accompanied by type II respiratory failure.
5. Patients who cannot understand and sign an informed consent form.
6. Patients with mental illness, pregnant women, and other special populations.

Where it's running

  • Taizhou People's Hospital affiliated to Nanjing Medical University
    Taizhou, Jiangsu, China
    Recruiting

Study contacts

  • Principal investigator: Ming Chu, Doctor — Jiangsu Taizhou People's Hospital
  • Study coordinator: Yucheng Wu, Doctor
  • Email: 2567181759@qq.com
  • Phone: +8618360010750

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.